Revaccination for Hepatitis B in Previous Nonresponders Following Hepatitis C Eradication

被引:2
作者
Powell, Jesse G. [1 ]
Goble, Spencer R. [2 ]
Debes, Jose D. [3 ,4 ]
机构
[1] Hennepin Healthcare, Dept Gastroenterol & Hepatol, Minneapolis, MN USA
[2] Hennepin Healthcare, Dept Med, Minneapolis, MN USA
[3] Univ Minnesota, Dept Med, Minneapolis, MN USA
[4] Univ Minnesota, Dept Med, Mayo Mem Bldg,MMC 250,420 Delaware St SE, Minneapolis, MN 55455 USA
关键词
direct-acting antiviral; hepatitis B virus vaccine; hepatitis B virus vaccine nonresponse; hepatitis C virus; VACCINATION; INFECTION; VIRUS;
D O I
10.1093/infdis/jiad301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Patients with chronic hepatitis C virus (HCV) do not respond to hepatitis B virus (HBV) vaccination as efficiently as the general population. We assessed if revaccination after HCV treatment resulted in improved response.Methods Previous HBV vaccine nonresponders were prospectively recruited for revaccination after HCV eradication. Hepatitis B surface antibody (HBsAb) testing was performed 1 month after series completion.Results Follow-up HBsAb testing was performed in 31 of 34 enrolled patients with 21 (67.7%) reactive results. There were no significant differences in HBsAb reactivity based on age, sex, race, or advanced fibrosis presence.Conclusions HBV vaccine nonresponders should be considered for revaccination following HCV cure. Patients with HCV who previously did not respond to HBV vaccine were revaccinated after HCV treatment with DAAs; 68% developed a proper response to the vaccine. Revaccination for HBV in previous nonresponders with HCV should be considered after HCV eradication.
引用
收藏
页码:341 / 345
页数:5
相关论文
共 15 条
[1]   Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies [J].
Abd El-Wahab, Ekram W. ;
Metwally, Mohammed ;
Lotfy, Nesma .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 (08) :882-894
[2]   Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut: Understanding Infection and Coinfection Risks in a Nonurban Population [J].
Akselrod, Hana ;
Grau, Lauretta E. ;
Barbour, Russell ;
Heimer, Robert .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 104 (09) :1713-1721
[3]   Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection [J].
Ashhab, Ashraf A. ;
Rodin, Holly ;
Campos, Marilia ;
Abu-Sulb, Ahmad ;
Hall, Jane A. ;
Powell, Jesse ;
Debes, Jose D. .
PLOS ONE, 2020, 15 (08)
[4]  
Chlabicz S, 2005, WORLD J GASTROENTERO, V11, P1798, DOI 10.3748/wjg.v11.i12.1798
[5]   Beyond one virus: vaccination against hepatitis B after hepatitis C treatment [J].
Debes, Jose D. ;
Singh, Dupinder .
LANCET INFECTIOUS DISEASES, 2018, 18 (03) :246-247
[6]  
Goble S., HEALTHCARE
[7]   Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large veterans administration medical centre [J].
Hachem, C. Y. ;
Kramer, J. R. ;
Kanwal, F. ;
El-Serag, H. B. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (09) :1078-1087
[8]  
Konstantinou D, 2015, ANN GASTROENTEROL, V28, P221
[9]   Response to anti-HBV vaccine and 10-year follow-up of antibody levels in healthcare workers [J].
La Fauci, V. ;
Riso, R. ;
Facciola, A. ;
Ceccio, C. ;
Lo Giudice, D. ;
Calimeri, S. ;
Squeri, R. .
PUBLIC HEALTH, 2016, 139 :198-202
[10]   Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta-analysis [J].
Liu, Jiaye ;
Wu, Hui ;
Chen, Hui .
HEPATOLOGY RESEARCH, 2018, 48 (02) :119-126